and demonstrates anti-inflammatory properties by reducing pro-inflammatory cytokines, inhibiting NLRP3 inflammasome activation, and blocking TLR4/NF-κB signaling in various pathological contexts (e.g., sepsis, hyperhomocysteinemia). The gene discussed is NFKB1; the disease is Sepsis.